FXPO:Ferrexpo dropped 7%, probably due to the uncertain situation on the Ukraine border, despite FXPO being nowhere near that. It also went ex-dividend so at least there's some cash coming soon.
SBTX:SkinBioTherapeutics also dropped 7% as one of my worst timed
purchases continues a downward spiral. News on sales or partner product
development can't come soon enough, but all we have is silence.
BLU:Blue Star Capital was bound to ease off as people take profits
following the recent rise. They dropped 5% of my original purchase price.
Biggest hit to value was OPTI:Optibiotix falling 5% which is 3p and
contributed £5,100 of this week's drop. We're overdue so much news and it
really needs to come soon.
Share of the Week was the only one to climb 5% or more as
JLP:Jubilee Metals
went up by 7% and seems to be slowly creeping up to where it should be.
Closest to the injection line for over a year.
Worst ever performance, just as I thought it couldn't get any worse.
Here's the ISA and shares portfolio after week 24 of year 7.
Weekly Change | |||
Cash | £33.30 |
+£0 | |
Portfolio cost | £72,195.21 | +£0 | |
Portfolio sell value (bid price-commission) | £45,498.91 | (-37.0%) | -£3,105.00 |
Potential profits | £2,275.29 | +£60 | |
Yr 7 Dividends | £22.16 | +£0 | |
Yr 7 Profit from sales | £3,664.29 | +£0 | |
Yr 7 projected avg monthly profit | £663.22 | (18.0%) | -£27.80 |
Total Dividends | £1,365.31 | +£0 | |
Total Profit from sales | £27,788.23 | +£0 | |
Average monthly cash profit |
£372.11 |
(10.1%) | -£1.12 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Compound performance | 65% | +0% |
Massive drop in value but £60 increase in potential profits thanks to JLP:Jubilee Metals. Long term performance still above target.
As with the overall portfolio the closest to injection line for over a year.
Utterly desperate.
The SIPP looks like this after week 320 overall and week 8 of year 7.
Weekly Change | ||||
Cash | £211.60 | -£104.52 | ||
Portfolio cost | £80,526.94 | +£104.52 | ||
Portfolio sell value (bid price - commission) |
£50,943.19 | (-36.7%) | -£3,086.92 | |
Potential profits | £63.63 | +£38.80 | ||
Yr 7 Dividends | £51.51 | +£0 | ||
Yr 7 Interest | £0 | +£0 | ||
Yr 7 Profit from sales | £381.04 | +£0 | ||
Yr 7 projected avg monthly profit | £216.15 | (5.3%) | -£30.88 | |
Total Dividends | £3,255.90 | +£0 | ||
Total Interest | £0.20 | +£0 | ||
Total Profit from sales | £24,105.67 | +£0 | ||
Average monthly cash profit | £358.94 | (8.7%) | -£1.12 | |
(Sold stocks profit + Dividends - Fees / Months) |
||||
Compound performance | 54% | +0% |
Automatic investment in iShares Physical Gold fund reduced cash by £104 and increased portfolio cost. Massive drop in value but potential profits up £38 thanks to PAF:Pan African Resources. Long term performance needs a boost to get to target but there's no chance of that any time soon.
A familiar story
As with everything else, the worst performance ever.
The trading account looks like this after week 286 overall and week 26 of year 6.
Weekly Change | |||
Cash | £259.74 | +£0 | |
Portfolio cost | £2,374.14 | +£0 | |
Portfolio sell value (bid price - commission) | £818.67 | (-65.5%) | -£57.35 |
Potential profits | £0.00 | +£0 | |
Year 6 Dividends | £0.00 | +£0 | |
Year 6 Profit | £0.00 | +£0 | |
Yr 6 projected avg monthly profit | £0.00 | (0%) | +£0 |
Dividends | £60.10 | +£0 | |
Profit from sales | £937.88 | +£0 | |
Average monthly cash profit | £15.12 | (7.6%) | -£0.05 |
(Sold stocks profit + Dividends - Fees / Months) |
It goes without saying this is as bad as everything else, in fact significantly worse.
Urrrg.
Continues the relentless decline.
Late writing up this week as I'm so miserable. At the halfway point of this week the portfolio is down another £700 so it is still getting worse. All I can do is hang on and hope for some sort of recovery, but at the moment I can't see any rays of hope. Every time there's a tick upwards it's followed by a bigger drop. Good news is met by at best stagnation but more often with a drop in price. Nothing to do but steel oneself for the next disappointing update.
No comments:
Post a Comment